ORTHOPEDIATRICS CORP (KIDS) - Dilution Analysis

10-Q filing | 23.6M shares outstanding

10-Q filing | 23.5M shares outstanding

10-Q filing | 23.2M shares outstanding

10-K filing | 23.1M shares outstanding

10-Q filing | 23.2M shares outstanding

8-K filing: OrthoPediatrics Corp. issued $50.0 million in aggregate principal amount of 4.75% Convertible Senior Notes due February 15, 2030, to Braidwell Transaction Holdings LLC - Series 10, with a maximum of 1,691,470 shares of common stock issuable upon conversion.

10-Q filing | 23.1M shares outstanding

8-K filing: OrthoPediatrics Corp. entered into a Term Loan Agreement for $25.0 million and a delayed draw term loan facility of up to $25.0 million, and issued $50.0 million in 4.75% Convertible Senior Notes due February 15, 2030 to Braidwell Transaction Holdings LLC - Series 10, with proceeds to be used for debt repayment, transaction fees, stock repurchase, and general corporate purposes; the Board of Directors approved a stock repurchase program of up to $5.0 million of the company's common stock.

10-Q filing | 22.8M shares outstanding

S-3 filing: Orthopediatrics Corp. files an S-3 to offer and sell up to $250,000,000 in common stock, preferred stock, debt securities, and warrants.

10-K filing | 22.7M shares outstanding

8-K filing: OrthoPediatrics Corp. acquired Boston Brace International, Inc. for $22 million in cash and issued restricted stock to certain Boston Brace employees and executives. ($2.5M proceeds)

10-Q filing | 22.8M shares outstanding

10-Q filing | 22.7M shares outstanding

10-Q filing | 22.5M shares outstanding

8-K filing: OrthoPediatrics Corp. issued 43,751 unregistered shares of common stock to the sellers of Medtech Concepts, LLC as part of the consideration for the purchase of Medtech. ($2.22M proceeds)

10-K filing | 20.9M shares outstanding

10-Q filing | 21.3M shares outstanding

8-K filing: OrthoPediatrics Corp. entered into an underwriting agreement for a public offering of 750,000 common shares at $55.00 per share and pre-funded warrants to purchase up to 1,525,000 shares to Squadron Capital LLC, with an option for the underwriters to purchase an additional 341,250 shares.

10-Q filing | 19.8M shares outstanding

10-Q filing | 19.4M shares outstanding

8-K filing: OrthoPediatrics Corp. issued 173,241 shares of common stock and awards of restricted stock of 48,591 shares related to the merger agreement with Mitchell Designs, Inc. ($11.4M proceeds)

10-K filing | 19.3M shares outstanding

10-Q filing | 19.3M shares outstanding

10-Q filing | 19.3M shares outstanding

10-Q filing | 19.2M shares outstanding

10-K filing | 19.7M shares outstanding

10-Q filing | 19.6M shares outstanding

10-Q filing | 19.5M shares outstanding

8-K filing: OrthoPediatrics Corp. entered into an underwriting agreement for a public offering of 1,600,000 shares of common stock at $47.00 per share, with an option for the underwriters to purchase an additional 240,000 shares. ($75.2M proceeds)

10-Q filing | 17.8M shares outstanding

8-K filing: OrthoPediatrics Corp. acquired ApiFix Ltd. and issued 934,783 shares of common stock as part of the consideration. ($37.0M proceeds)

S-3 filing: Orthopediatrics Corp. files an S-3 form to offer and sell up to $200,000,000 in the aggregate of common stock, preferred stock, debt securities and warrants from time to time in one or more offerings.

10-K filing | 16.9M shares outstanding